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Available online 29 March 2017The homeodomain transcription factor Shox2 controls the development and function of the native cardiac pace-
maker, the sinoatrial node (SAN). Moreover, SHOX2mutations have been associatedwith cardiac arrhythmias in
humans. For detailed examination of Shox2-dependent developmental mechanisms in SAN cells, we established
a murine embryonic stem cell (ESC)-based model using Shox2 as a molecular tool. Shox2+/+ and Shox2−/− ESC
cloneswere isolated and differentiated according tofive different protocols in order to evaluate themost efficient
enrichment of SAN-like cells. Expression analysis of cell subtype-specific marker genes revealed most efficient
enrichment after CD166-based cell sorting. Comparative cardiac expression profiles of Shox2+/+ and Shox2−/−
ESCs were examined by nCounter technology. Among other genes, we identified Nppb as a novel putative
Shox2 target during differentiation in ESCs. Differential expression of Nppb could be confirmed in heart tissue
of Shox2−/− embryos. Taken together, we established an ESC-based cardiac differentiationmodel and successful-
ly purified Shox2+/+ and Shox2−/− SAN-like cells. This now provides an excellent basis for the investigation of
molecular mechanisms under physiological and pathophysiological conditions for evaluating novel therapeutic
approaches.
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Due to their potential to differentiate into all cell types of the three
primary germ layers, embryonic stem cells (ESCs) are perfectly suited
to investigate early developmental processes such as heart develop-
ment (Wobus, 2001). The investigation of cardiac cell subtype specifica-
tion in differentiating ESCs provides a promising source for cell-based
heart therapies including biological pacemakers.
The rhythmic beating of the heart is initiated by a population of
pacemaker cells located in the sinoatrial node (SAN) (Opthof, 1988).
The development of the SAN involves a multistep differentiation pro-
cess of specialized cells originating from multipotent stem cells
(Christoffels et al., 2010). Functional impairment of these cells leads to
arrhythmogenic heart diseases with increased mortality risk
(Choudhury et al., 2015). The elucidation of molecular mechanisms inetics, Department of Human
.
.de (G.A. Rappold).
. This is an open access article undernormal and impaired SAN development and function is therefore of cru-
cial clinical relevance.
Previously, we and others have demonstrated that a gene regulatory
network involving the homeodomain transcription factor Shox2 con-
trols cardiac pacemaker development and specification in mouse and
zebrafish (Blaschke et al., 2007; Espinoza-Lewis et al., 2009; Puskaric
et al., 2010; Hoffmann et al., 2013; Ye et al., 2015). Homozygous Shox2
deletion leads to early embryonic lethality due to developmental de-
fects of the SAN, while heterozygous mice are viable and fertile
(Blaschke et al., 2007). In zebrafish embryos, the loss of Shox2 substan-
tially impairs pacemaker functionwith severe bradycardia and irregular
heartbeat (Blaschke et al., 2007; Hoffmann et al., 2013). In linewith this,
we recently showed for the first time that SHOX2 mutations associate
with atrial fibrillation, themost common cardiac arrhythmia in humans
(Hoffmann et al., 2016).
Shox2 activates the SAN genetic program either by direct regulation
of its target Isl1, which controls cardiac pacemaker subtype identity
(Hoffmann et al., 2013; Dorn et al., 2015; Vedantham et al., 2015), or
by antagonizing the transcriptional output of Nkx2.5 (Espinoza-Lewis
et al., 2009, 2011; Ye et al., 2015). Shox2-deficient mice used in thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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expression of SAN-specific genes and ectopic expression of chamber-
specific genes (Blaschke et al., 2007; Puskaric et al., 2010; Hoffmann
et al., 2013). Furthermore, the SHOX2promoter is suited for the isolation
ofmouse ESC-derived SAN-like cells and as lineage-specific promoter to
drive the expression of a voltage-sensitive fluorescent protein in nodal-
like human induced pluripotent stem cell-derived cardiomyocytes
(Hashem and Claycomb, 2013; Hashem et al., 2013; Chen et al., 2017).
In addition, Shox2 overexpression during embryonic and mesenchymal
stem cell differentiation strongly favours pacemaker cell specification
(Ionta et al., 2015; Feng et al., 2016). Shox2 among other embryonic
transcription factors such as Tbx3, Tbx18 or Isl1 (Bakker et al., 2012;
Kapoor et al., 2013; Dorn et al., 2015), is able to direct pacemaker cell
type determination. Taken together, Shox2 represents one of the
major genes in the developing SAN and proper function is of crucial
relevance regarding the origin of arrhythmogenic heart diseases. The
elucidation of the underlying molecular mechanisms is therefore
mandatory. To provide a cell-model for unravelling these mechanisms
in health and disease, we established a stem cell-based cardiac differen-
tiation model using Shox2 as a molecular tool.
2. Material and methods
2.1. Generation of ESC clones from Shox2-deficient mice
Superovulation was induced in viable, female Shox2+/− C57BL/6
mice (Blaschke et al., 2007), followed by mating. At embryonic stage
E3.5 single blastocysts were collected and plated on mouse embryonic
fibroblasts (MEFs). Preparation and MitomycinC (Sigma-Aldrich)-inac-
tivation of MEFs were described earlier (Wobus et al., 2002). Collected
blastocysts were cultivated for 5 days (d) in ESC proliferation medium
(Wobus et al., 2002). Thereafter, the inner cell mass (ICM) of adherent
blastocysts was mechanically picked, dissociated with trypsin/EDTA
(Gibco) and replated onto MEFs in ESC proliferation medium. Cells
were always cultivated at 37 °C with 5% CO2 and 95% humidity. Gener-
ated ESC cloneswere genotyped as previously described (Blaschke et al.,
2007).
2.2. Cultivation and differentiation of ESC clones
Generated ESC clones and the mouse ESC line R1 (Nagy et al., 1993)
were cultivated and expanded onMEFs in ESC proliferationmedium. In
order to investigate the differentiation properties of the generated
Shox2+/+ and Shox2−/− ESC clones, cells were differentiated according
to a standard hanging drop protocol (600 cells/drop, plating of embry-
oid bodies (EBs) after 7d) and morphologically characterized as de-
scribed earlier (Wobus et al., 2002). Briefly, 7d EBs were plated
separately in 24-well plates (one EB/well) coated with 0.1% gelatin
(Sigma-Aldrich). Every second or third day, the appearance of either
beating cardiomyocytes, neurons or skeletal muscle cells per EB was
assessed by bright field microscopy. The appearance of the respective
cell type per EB was counted, not the total number of the respective
cells. The morphological analysis was limited to ectodermal and meso-
dermal cell derivatives, as endodermal cells are difficult to characterize
by morphology.
2.3. Alkaline phosphatase (ALP) staining
Detection of ALP in generated ESC clones was carried out using an
ALP-Kit (Sigma-Aldrich) as recommended by the manufacturer.
2.4. Immunofluorescence (IF) staining
IF analyses were performed with generated ESC clones and isolated
beating cardiac clusters. ESC clones were stained with rabbit anti-Oct4
(1:120; abcam) and mouse anti-SSEA-1 (1:50; abcam) and visualizedby incubation with anti-rabbit Alexa Fluor (AF) 488 (1:200; Molecular
Probes) and anti-mouse Cy3 (1:600; Dianova). Beating cardiac clusters
isolated at differentiation stage 7 + 12d (Maltsev et al., 1993) from
Shox2+/+ and Shox2−/− ESC clones were incubated with rabbit anti-
Shox2 (1:200; abcam) and mouse anti-Titin (1:200, provided by Prof.
Fürst, University of Bonn, Germany) and visualized with anti-rabbit AF
488 and anti-mouse AF 568 (both 1:250; Molecular Probes). Counter-
stain was performed using Hoechst 33342 nuclear staining dye
(ThermoFisher Scientific).2.5. Quantitative real-time PCR (qPCR)
Total RNAwas extracted with TRIzol reagent (Invitrogen) according
to the manufacturer's instructions. Reverse transcription was per-
formed using the SuperScript III First-Strand Synthesis Kit (Invitrogen).
qPCR was conducted using the SYBR Green Lo-Rox Fast Mix (Bioline)
and the ABI 7500 Fast Real-Time PCR system (Applied Biosystems).
Each sample was analyzed in duplicates and relative mRNA levels
were assessed using the Relative Standard CurveMethod by normaliza-
tion to the reference genes succinate dehydrogenase complex subunit A
(Sdha1) and hypoxanthine phosphoribosyltransferase 1 (Hprt1). Calcu-
lated values are means ± SD and presented as fold-change. Oligonucle-
otide sequences are given in Supplementary Table 1.2.6. Enrichment of ESC-derived SAN-like cells
To enrich ESC-derived SAN-like cells, the R1mouse ESC line was dif-
ferentiated according to five different protocols (Fig. 2A, Table 1). In
brief, protocol A utilizes AG1478 (Chen et al., 2013), whereas protocol
B utilizes Suramin (Wiese et al., 2011) for the enrichment of ESC-de-
rived SAN-like cells. Protocol Cwas established according to the conven-
tional hanging drop protocol for cardiac differentiation (Wobus et al.,
2002) with additional treatment by Suramin. Protocol D differs in the
initial amount of cells used for EB formation, the length of suspension
culture and media composition (Hashem et al., 2013). Scavone et al.
established a FACS-based protocol to isolate SAN-like cardiomyocytes
during murine ESC differentiation using the surface marker CD166
(Scavone et al., 2013). This protocol (E) was modified with regard to
media composition and the predetermined number of ESCs in order to
improve the efficiency of SAN cell isolation. Fluorescent activated cell
sorting (FACS) in protocol E was performed by the FACS Core Facility
of the Department of Medicine V in Heidelberg using a FACS Aria II
SORP cell sorter. Results were evaluated by qPCR assessing the expres-
sion of Shox2 and Hcn4. Cells that had undergone treatment according
to the most efficient protocol E were further investigated by compara-
tive expression analysis using cell type-specific marker genes (Supple-
mentary Table 1). Thereafter, protocol E was also applied to the
Shox2+/+ ESC clone for subsequent comparative expression analysis
(Supplementary Table 1).2.7. nCounter expression analysis of Shox2+/+ and Shox2−/− CD166+ SAN-
like cells
The cardiac expression profile of CD166+ Shox2+/+ and Shox2−/−
SAN-like cells (7 + 1d) was investigated by nCounter expression anal-
ysis at the nCounter Core Facility Heidelberg using the nCounter Dx
analysis system GEN1. Detailed probe design is given in Supplementary
Table 2. The workflow is described at http://www.nanostring.com/
elements/workflow. Background correction and normalization of
data was performed using the nSolver Analysis Software 3.0
(NanoString Technologies). Most stable expressed genes were chosen
for normalization based on the geNorm method. Log2 values are
presented as ±SD.
Table 1















A Chen et al.,
2013
1000 30 μl 3d 2d 5d 5 + 9d-5 + 11d
5 μM AG1478 (Biomol)
20% 5 + 12d
B Wiese et al.,
2011
400 20 μl 2d 5d 7d 5d-7d 500 μM Suramin
(Sigma-Aldrich)




600 20 μl 2d 5d 7d 5d-7d 500 μM Suramin
(Sigma-Aldrich)
20% 7 + 10d
D Hashem et
al., 2013




600 20 μl 2d 5d 7d 7 + 1d
CD166 FACS
(eBiosciences)
20% 7 + 1d
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3.1. Isolation and characterization of ESCs from Shox2-deficient mice
We have established three genotypically different ESC lines
(Shox2+/+, Shox2+/− and Shox2−/−) by isolating pluripotent stem cells
from the inner cell mass (ICM) of Shox2-deficient mouse blastocysts at
stage E3.5. The ICM was separated from the blastocysts after 5d in co-
culture on murine embryonic fibroblasts (MEFs). After expansion, the
genotype of each isolated ESC clone was determined by PCR (data not
shown). In total, at least two different ESC lines per genotype have
been isolated. For further characterization, one ESC clone per genotype
was analyzed, respectively (data for Shox2+/− ESC clone are not
shown). Pluripotency was verified by immunofluorescent staining of
the keymarkers Oct4 and SSEA-1. Complementing alkaline phosphatase
activity analysis resulted in a distinct red staining of ESC colonies, while
the surrounding MEFs remained unstained (Fig. 1A).
Our standard differentiation protocol includes embryoid body (EB)
formation for 2d in hanging drops followed by 5d in suspension culture.
Further differentiation was initiated by plating of EBs after 7d. Expres-
sion analysis of the pluripotency marker Pou5f1 by qPCR revealed a
strong decrease in differentiated ESCs after 7+ 12d compared to undif-
ferentiated controls (d0) for both, wildtype (WT) and knockout (KO)
(Fig. 1B). Lineage-specific marker gene qPCR analysis representing the
three primary germ layers (mesoderm: Des; endoderm: Sox17; ecto-
derm:Nes) pointed to a spontaneous EB differentiation of all ESC clones
(Fig. 1B). Morphological evaluation calculating the percentage of EBs
with specific differentiated cell types confirmed the potential of all iso-
lated ESC clones to differentiate into cardiomyocytes, skeletal muscle
and neuronal cells (Fig. 1C). Further analysis of the differentiated ESC
clones verified the expected Shox2 expression profile on transcript
(Fig. 1D) and protein (Fig. 1E) levels. No Shox2 transcript or protein
was detectable in the Shox2 KO ESCs. Furthermore, the co-staining of
differentiated ESCs with the sarcomere protein Titin confirmed the dif-
ferentiation into cardiomyocytes (Fig. 1E).
3.2. Differentiation of ESCs into cardiomyocytes of the SAN subtype
Various protocols for the differentiation of ESCs into specialized
cardiomyocytes have been established in the past. To evaluate the
most efficient enrichment of SAN-like cells in vitro, we testedfive differ-
entiation protocols (Fig. 2A; Table 1) using the established and commer-
cially available ESC line R1.We compared three previously published (A,
B, D) and two specificallymodified protocols (C, E) to assess the efficien-
cy of SAN cell enrichment by marker gene expression analysis. All five
protocols applied the hanging drop approach (Fig. 2A; Table 1). To in-
vestigate and compare the subtype specification of SAN-like cells during
differentiation of mouse ESCs, comparative expression analysis of the
SAN-specific marker genes Shox2 and Hcn4 was performed by qPCR(Fig. 2B). Most efficient enrichment of SAN-like cells was achieved
with protocol E. To further evaluate this differentiation protocol on
cell type specification, expression analysis of additional cell type-specif-
ic marker genes was carried out (Fig. 2C). We could show that the SAN
genes CD166, Shox2 and Hcn4 and the general cardiac cell type-specific
markers Gata4 (core cardiac transcription factor), Nppa (working
myocard), Actc1 (pan cardiac marker) and Ddr2 (cardiac fibroblasts)
are significantly enriched in CD166+ cells compared to unsorted con-
trols. In contrast, a clear reduction of markers such as Sox17
(mesendoderm), Hnf6α (endoderm) and CD105 (endothelium) was
demonstrated, while Tubb3 (neurons) and Acta2 (smooth muscle)
showed no difference in expression levels between unsorted controls
and CD166+ ESCs (Fig. 2C).
After successful differentiation of the ESC line R1 into
cardiomyocytes of the SAN subtype, protocol E was also applied to the
isolated Shox2+/+ ESCs. Expression analysis of different SAN marker
genes (CD166, Shox2,Hcn4, Tbx18) by qPCR points to a highly significant
enrichment of SAN-like cardiomyocytes in CD166+ cells compared to
unsorted controls (Fig. 2D).
3.3. Comparative expression analysis of Shox2+/+ vs Shox2−/− SAN-like
cells by nCounter technology
For detailed investigation of differentiated CD166+ Shox2+/+ vs
Shox2−/− SAN-like cells, we performed a comparative expression anal-
ysis using the nCounter technology (Fig. 3). This RNA quantification
technology allows the multiplexed target measurement from only
100 ng of input with high sensitivity and specificity. We examined the
expression levels of cell type specific markers (Supplementary Table
2) including cardiac cell subtypes, pluripotencymarkers and non-cardi-
ac cell markers (e.g. neuronal markers). While no differences or no ex-
pression was detected for the non-cardiac markers (data not shown),
differential expression was observed for most of the analyzed cardiac
genes. In total, six of nine investigated SAN-specific genes were signifi-
cantly downregulated in Shox2-deficient cells including Shox2, Hcn4,
Tbx18, Tnni1, Cacna1h, Gjc1, while Cacna1g and Gjd3 showed the same
trend but did not reach statistical significance (Fig. 3B). Consistent
with previously described data, the myocardial-specific gene Gja1
(Cx43) was upregulated, while Acta1 and Nppa were not significantly
differently expressed (Fig. 3C). Remarkably, the working myocard
marker Nppb was significantly upregulated in Shox2−/− SAN-like cells.
To validate the differential expression identified in ESCs, we also exam-
ined Nppb expression in right atrial tissue (including the SAN) of Shox2-
KOembryos compared toWT. This analysis revealed a significant upreg-
ulation of Nppb and confirmed this gene as a putative target of Shox2 in
ESCs and mouse atrial tissue (Fig. 3D). The expression of the
pluripotency markers Pou5f1 and Nanog was significantly increased in
the Shox2−/− cells, suggesting a lower differentiation potential of
these cells (Fig. 3E).
Fig. 1. Isolation and spontaneous differentiation of ESCs from Shox2-deficient mice. A) Characterization of undifferentiated ESCs by ALP staining (ESC colonies visualized in red) and
immunofluorescent detection of Oct4 (green) and SSEA-1 (red). Nuclei were counterstained with Hoechst 33342 (blue). Scale bars: ALP 100 μm; IF 50 μm. B) Expression analyses of
pluripotency and lineage-specific marker genes in differentiated Shox2+/+ and Shox2−/− ESCs at 7 + 12d (n = 3) compared to undifferentiated ESCs d0 (n = 2). C) Morphological
evaluation of Shox2+/+ (n = 4) and Shox2−/− (n = 5) ESCs calculating the percentage of EBs with specific cell types at various time points of differentiation: cardiomyocytes (CM),
neuronal cells (NC), skeletal muscle cells (SMC); data table (value/SEM). D) Relative mRNA expression of Shox2 during differentiation of Shox2+/+ and Shox2−/− ESC clones (n = 3).
E) Immunofluorescent detection of the sarcomere protein Titin (green) and Shox2 (red) in isolated beating cardiomyocytes (7 + 12d) derived from Shox2+/+ and Shox2−/− ESC
clones. Nuclei were counterstained with Hoechst 33342 (blue). Scale bars: 20 μm.
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We have previously demonstrated that a gene regulatory network
involving the homeodomain transcription factor Shox2 controls the de-
velopment and function of the cardiac pacemakerwith a highly restrict-
ed expression pattern in the SAN (Blaschke et al., 2007; Puskaric et al.,
2010; Hoffmann et al., 2013). Shox2-deficiency is associated with im-
paired SAN function and increased susceptibility to atrial fibrillation
(Blaschke et al., 2007; Hoffmann et al., 2016). The molecular mecha-
nisms underlying Shox2 function in health and disease are barely un-
derstood. This prompted us to develop a murine ESC-based cardiac
differentiationmodel using Shox2-deficientmice, whichmay contribute
fundamentally to the current knowledge of the intrinsic genetic pro-
gram. The enrichment of an ESC-derived SAN-like cell population is a
prerequisite to specifically investigate signaling pathways, mandatory
for differentiation of pacemaker cells. The differentiation of ESC-derived
cardiomyocytes is influenced by many parameters, including the initial
number of cells per EB, media composition and specific additives
(Wobus et al., 2002). We applied and modified in total five differentia-
tion protocols using pharmacological treatments or FACS-based selec-
tion (Wobus et al., 2002; Wiese et al., 2011; Chen et al., 2013; Hashem
et al., 2013; Scavone et al., 2013) and compared the expression levels
of SAN-specific marker genes (Shox2 and Hcn4). Most efficient enrich-
ment of SAN-like cells was observed with a previously describedFACS-based differentiation protocol (Scavone et al., 2013). The media
composition and the predetermined number of ESCs were adapted to
our standard differentiation protocol. For FACS analysis the surface
marker CD166was applied, as it is specifically but transiently expressed
in the prospective SAN during embryonic development (Hirata et al.,
2006). FACS-based selection does not influence molecular mechanisms
compared to chemical-based enrichment procedures, which is a major
advantage of this protocol. However, a limitation of this methodology
is the restricted amount of CD166+ cells. Only 5% of the sorted cells
were CD166+, consequently an enormous number of differentiated
ESCs are required to obtain a sufficient cell number for RNA isolation
and subsequent expression analysis. To overcome this challenge,
nCounter technology was used for comparative expression analysis, as
very low amounts of inputmaterial (100 ng) are sufficient.Weobserved
a significant downregulation ofmost SAN-specific genes (6/9 targets) in
the Shox2−/− cells. This confirms the specificity of our established ESC-
based cardiac differentiationmodel and recapitulates the data observed
in the mouse model. The Shox2−/− SAN-like cells showed highly in-
creased transcript levels for the pluripotency markers Pou5f1 and
Nanog, suggesting that Shox2-deficiency may influence the differentia-
tion potential of ESCs and thereby explain the hypoplastic SAN pheno-
type observed in the KO mouse.
Most remarkably, we identified Nppb (Bnp), a well-studied marker
in cardiovascular disease, as a novel putative Shox2 target gene. This
Fig. 2. Enrichment of ESC-derived SAN-like cells. A) Schematic representation of the differentiation protocols. B) Comparison of differentiation protocols (A–E) with R1 ESCs (n=2) using
Shox2 andHcn4. C) Expression analysis of cell type-specificmarker genes using CD166 FACS-sorted (red bars) andunsorted (grey bars) R1 ESCs (n=2)applied tomethod E (Scavone et al.,
2013; modified). D) Expression analysis of CD166 and SAN marker genes using CD166+ (red bars) and unsorted (grey bars) Shox2+/+ ESCs (n= 3) applied to method E (Scavone et al.,
2013; modified). p-values were determined by an unpaired t-test (*p b 0.05; **p b 0.01; ***p b 0.001; ****p b 0.0001).
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significantly upregulated in Shox2−/− SAN-like cells and in right atrial
tissue of Shox2-KO embryos. Interestingly, NPPB (BNP) has been previ-
ously described as direct target of SHOX2 and SHOX (a highly homolo-
gous transcription factor) in skeletal development (Marchini et al.,
2007; Aza-Carmona et al., 2014) suggesting this gene as reliable target
also in heart development. Recently, we could link SHOX2 mutations
to atrial fibrillation, the most common arrhythmia in humans
(Hoffmann et al., 2016). In turn, elevated BNP levels and higher NPPBmRNA expression have been detected in subjects with atrial fibrillation
(Tuinenburg et al., 1999; Silvet et al., 2003) suggesting that our generat-
ed ESCs have the potential to serve as an excellent in vitro model
system. Taken together, we established an ESC-based cardiac differenti-
ation model and successfully purified Shox2+/+ and Shox2−/− SAN-like
cells. This provides a fundamental basis for the investigation of molecu-
lar pathways under physiological and pathophysiological conditions
and may serve as drug testing system for evaluating novel therapeutic
approaches.
Fig. 3. Comparative expression analysis of CD166+ Shox2+/+ and Shox2−/− SAN-like cells by nCounter technology after 7 + 1d. A) Expression of SAN, workingmyocard and pluripotency
markers was analyzed in CD166+ Shox2+/+ cardiomyocytes (n = 3). B) Expression differences of SAN markers between CD166+ Shox2+/+ and Shox2−/− SAN-like cells (n = 3). C)
Expression differences of working myocard markers between CD166+ Shox2+/+ and Shox2−/− SAN-like cells (n = 3). D) nCounter analysis revealed differential expression of Nppb in
CD166+ Shox2−/− ESCs and confirmed Nppb as significantly differential expressed gene in right atria of E11.5 Shox2-KO embryos (n = 3). E) Expression differences of pluripotency
markers between CD166+ Shox2+/+ and Shox2−/− SAN-like cells (n = 3). p-values were determined by an unpaired t-test (*p b 0.05; **p b 0.01; ***p b 0.001).
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